Reproducible erythroid aplasia caused by mycophenolate mofetil - PubMed

Case Reports

Reproducible erythroid aplasia caused by mycophenolate mofetil

K Arbeiter et al. Pediatr Nephrol. 2000 Mar.

Abstract

Anemia secondary to mycophenolate mofetil (MMF) was recently described in experimental animals. A clinical association between MMF and anemia has been observed, but there are no proven reports. We describe a girl with chronic graft failure who developed erythroid aplasia under immunosuppression with MMF. She showed prompt resolution when MMF was discontinued and a recurrence of this clinical course when MMF was restarted. As re-challenge with a medication is the most definitive approach for showing a direct relationship between the drug and the side effect, this case clearly demonstrates that MMF can cause erythroid aplasia.

Similar articles

• Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients.

  Engelen W, Verpooten GA, Van der Planken M, Helbert MF, Bosmans JL, De Broe ME. Engelen W, et al. Clin Nephrol. 2003 Aug;60(2):119-24. doi: 10.5414/cnp60119. Clin Nephrol. 2003. PMID: 12940614

• Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus.

  Doherty T, Austin SK, Newell B, Kiely PD. Doherty T, et al. Lupus. 2013 Feb;22(2):213-5. doi: 10.1177/0961203312469262. Epub 2012 Dec 20. Lupus. 2013. PMID: 23257406

• Treatment of pure red-cell aplasia with cyclosporine in a renal transplant patient.

  Yildirim R, Bilen Y, Keles M, Uyanik A, Gokbulut P, Aydinli B. Yildirim R, et al. Exp Clin Transplant. 2013 Feb;11(1):63-5. doi: 10.6002/ect.2012.0066. Epub 2012 Aug 11. Exp Clin Transplant. 2013. PMID: 22891934

• Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone.

  Pérgola PE, Kancharla A, Riley DJ. Pérgola PE, et al. Transplantation. 2001 Apr 15;71(7):994-7. doi: 10.1097/00007890-200104150-00028. Transplantation. 2001. PMID: 11349738 Review.

Cited by

• Diagnostic application of the A(1c) assay in renal disease.

  Sharif A, Baboolal K. Sharif A, et al. J Am Soc Nephrol. 2010 Mar;21(3):383-5. doi: 10.1681/ASN.2010010031. Epub 2010 Feb 4. J Am Soc Nephrol. 2010. PMID: 20133482 Free PMC article. No abstract available.

• Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome.

  Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ. Dorresteijn EM, et al. Pediatr Nephrol. 2008 Nov;23(11):2013-20. doi: 10.1007/s00467-008-0899-6. Epub 2008 Jul 12. Pediatr Nephrol. 2008. PMID: 18622632 Free PMC article. Clinical Trial.

• Pure red cell aplasia associated with type I autoimmune polyglandular syndrome-successful response to treatment with mycophenolate mofetil: case report and review of literature.

  Bakrac M, Jurisic V, Kostic T, Popovic V, Pekic S, Kraguljac N, Colovic M. Bakrac M, et al. J Clin Pathol. 2007 Jun;60(6):717-20. doi: 10.1136/jcp.2006.042671. Epub 2007 Jan 12. J Clin Pathol. 2007. PMID: 17220208 Free PMC article. Review. No abstract available.

• Anemia in Pediatric Kidney Transplant Recipients-Etiologies and Management.

  Kouri A, Balani S, Kizilbash S. Kouri A, et al. Front Pediatr. 2022 Jun 20;10:929504. doi: 10.3389/fped.2022.929504. eCollection 2022. Front Pediatr. 2022. PMID: 35795334 Free PMC article. Review.

• Anemia in pediatric renal transplant recipients.

  Kausman JY, Powell HR, Jones CL. Kausman JY, et al. Pediatr Nephrol. 2004 May;19(5):526-30. doi: 10.1007/s00467-004-1427-y. Epub 2004 Mar 9. Pediatr Nephrol. 2004. PMID: 15007719

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Research Materials

  • NCI CPTC Antibody Characterization Program